InsidersTradesSigma
Follow the 华大基因 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 华大基因 has recorded 4 reports. Market capitalisation: €15.3bn. The latest transaction was filed on 22 September 2025 (Sale). Among the most active insiders: 汪建. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
华大基因 is a genomics company that provides sequencing and genetic analysis services. It is listed on the XSHE market.